Drug Delivery Systems
暂无分享,去创建一个
[1] Jon S. C. Yu,et al. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate , 2005, Journal of neurochemistry.
[2] B. Stacey. Management of Peripheral Neuropathic Pain , 2005, American journal of physical medicine & rehabilitation.
[3] Bengt Linderoth,et al. Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot study , 2004, European journal of pain.
[4] S. Hassenbusch,et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. , 2004, Journal of pain and symptom management.
[5] L. Tonder,et al. Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain. , 2004, Pain medicine.
[6] H. Gerber. Intrathecal morphine for chronic benign pain. , 2003, Best practice & research. Clinical anaesthesiology.
[7] K. Burchiel,et al. A Prospective, Randomized Trial of Intrathecal Injection vs. Epidural Infusion in the Selection of Patients for Continuous Intrathecal Opioid Therapy , 2003, Neuromodulation : journal of the International Neuromodulation Society.
[8] S. Abram,et al. Intrathecal Baclofen in Pain Management , 2003, Regional Anesthesia & Pain Medicine.
[9] T. Deer,et al. Prevention of Intrathecal Drug Delivery Catheter‐Related Complications , 2003, Neuromodulation : journal of the International Neuromodulation Society.
[10] Krishna Kumar,et al. Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. , 2002, Journal of neurosurgery.
[11] M. L. Gay. Spinal Morphine in Nonmalignant Chronic Pain: A Retrospective Study in 39 Patients , 2002, Neuromodulation : journal of the International Neuromodulation Society.
[12] S. Hassenbusch,et al. Intrathecal clonidine in the treatment of intractable pain: a phase I/II study. , 2002, Pain medicine.
[13] S. Hassenbusch,et al. An Updated Interdisciplinary Clinical Pathway for CRPS: Report of an Expert Panel , 2002, Pain practice : the official journal of World Institute of Pain.
[14] L. J. Roberts,et al. Outcome of intrathecal opioids in chronic non‐cancer pain , 2001, European journal of pain.
[15] R. Coffey,et al. Inflammatory Mass Lesions Associated with Intrathecal Drug Infusion Catheters: Report and Observations on 41 Patients , 2001, Neurosurgery.
[16] M. Kelly,et al. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. , 2001, Surgical neurology.
[17] J. de Andrés,et al. Application of a Psychological Decision Algorithm for the Selection of Patients Susceptible to Implantation of Neuromodulation Systems for the Treatment of Chronic Pain. A Proposal , 2000, Neuromodulation : journal of the International Neuromodulation Society.
[18] J. van Buyten,et al. Endocrine consequences of long-term intrathecal administration of opioids. , 2000, The Journal of clinical endocrinology and metabolism.
[19] T. Yaksh,et al. Long‐term spinal analgesic delivery: A review of the preclinical and clinical literature , 2000, Regional anesthesia and pain medicine.
[20] S. Hassenbusch,et al. Cost Effectiveness of Intrathecal Therapy for Pain , 1999, Neuromodulation : journal of the International Neuromodulation Society.
[21] A. Koulousakis,et al. Drug Adverse Events and System Complications of Intrathecal Opioid Delivery for Pain: Origins, Detection, Manifestations, and Management , 1999, Neuromodulation : journal of the International Neuromodulation Society.
[22] T. Deer,et al. Intrathecal Therapy for Cancer and Nonmalignant Pain: Patient Selection and Patient Management , 1999, Neuromodulation : journal of the International Neuromodulation Society.
[23] V. Tronnier,et al. Neuromodulation of pain: A consensus statement prepared in Brussels 16–18 January 1998 by the following task force of the European Federation of IASP Chapters (EFIC) , 1998, European journal of pain.
[24] S. Hassenbusch,et al. Clinical realities and economic considerations: economics of intrathecal therapy. , 1997, Journal of pain and symptom management.
[25] B. Ginsberg,et al. Monitoring practices following epidural analgesics for pain management: a follow-up survey. , 1997, Journal of pain and symptom management.
[26] R. Luther,et al. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. , 1996, The Journal of pharmacology and experimental therapeutics.
[27] W. Winkelmüller,et al. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. , 1996, Journal of neurosurgery.
[28] R. Penn,et al. Intraspinal morphine for chronic pain: a retrospective, multicenter study. , 1996, Journal of pain and symptom management.
[29] S. Hassenbusch,et al. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. , 1995, Journal of pain and symptom management.
[30] G. Maddern,et al. Implantable spinal infusion devices for chronic pain and spasticity: an accelerated systematic review , 2003 .
[31] Ruth E. Brown,et al. Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. , 1997, Clinical therapeutics.